Healthcare Utilization and Direct Costs in Patients with Ankylosing Spondylitis Using a Large US Administrative Claims Database
ConclusionIn this analysis of claims data, increased outpatient and pharmacy costs were key contributors to higher all-cause total healthcare costs in US patients with AS.FundingNovartis Pharmaceuticals Corporation, East Hanover, NJ.
Source: Rheumatology and Therapy - Category: Rheumatology Source Type: research
More News: Ankylosing Spondylitis | Databases & Libraries | Emergency Medicine | Healthcare Costs | Medicare | Rheumatology | Study | USA Health